FEATURED, Markets Global Blood Therapeutics, Inc. (NASDAQ:GBT) Stock Slumped 6.05% in Pre-market Posted onJune 26, 2019June 26, 2019 Global Blood Therapeutics, Inc. (NASDAQ:GBT) announced an agreement to sell approximately $200.0 million in shares of its common stock in a registered underwritten public offering. In …